|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01134679 |
|
Date of registration:
|
23/07/2009 |
|
Primary sponsor: |
|
|
Public title:
|
(EASY)-IMProving Adherence to Clopidogrel Trial (IMPACT))
EASY-IMPACT |
|
Scientific title:
|
Telephone Contacts to Improve Adherence to Dual Anti-Platelet Therapy Following Drug-Eluting Stent Implantation; A Randomized Controlled-Trial |
|
Date of first enrolment:
|
June 2009 |
|
Target sample size:
|
300 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01134679 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
|
|
|
Countries of recruitment
|
|
Canada
| | | | | | | |
|
Contacts
|
|
Name:
|
Stephane Rinfret, MD MSc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
IUCPQ |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Percutaneous Coronary Intervention with implantation of Drug-Eluting Stent
- Prescription for Plavix and Aspirin
Exclusion Criteria:
- Patients frequenting more than one pharmacy
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Coronary Artery Disease
|
|
Intervention(s)
|
|
Behavioral: Multi-disciplinary disease management approach
|
|
Primary Outcome(s)
|
|
the number of days with available Clopidogrel and Aspirin (from pharmacy records)
[Time Frame: 1 year]
|
|
Secondary Outcome(s)
|
|
the adhesion to Clopidogrel and Aspirin as self-reported by patients
[Time Frame: 1 year]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|